Journal of Ethnopharmacology 151 (2014) 652–659
Contents lists available at ScienceDirect
Journal of Ethnopharmacology
journal homepage: www.elsevier.com/locate/jep
Chemical composition, cytotoxicity and in vitro antitrypanosomal
and antiplasmodial activity of the essential oils of four Cymbopogon
species from Benin$
Salomé Kpoviessi a,b,c, Joanne Bero b, Pierre Agbani d, Fernand Gbaguidi a,c,
Bénédicta Kpadonou-Kpoviessi a, Brice Sinsin d, Georges Accrombessi a, Michel Frédérich e,
Mansourou Moudachirou c, Joëlle Quetin-Leclercq b,n
a
Laboratory of Physic and Synthesis Organic Chemistry (LaCOPS), University of Abomey-Calavi (UAC), Faculty of Sciences and Technics (FAST),
BP: 4521 Cotonou, Benin
b
Pharmacognosy Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B1 7203 Av. E. Mounier 72, B-1200
Bruxelles, Belgium
c
Laboratory of Pharmacognosy and Essential oils (LAPHE), University of Abomey-Calavi (UAC), Faculty of health Sciences (FSS), Faculty of Sciences
et Technics (FAST), 01 BP: 188 Cotonou, Benin
d
Laboratory of Applied Ecology (LEA), University of Abomey-Calavi (UAC), Faculty of Agronomic Sciences (FSA), 03 BP: 1974 Cotonou, Benin
e
Université de Liège, Drug Research Center, Laboratoire de Pharmacognosie, Av. de l'Hôpital 1, B36, B-4000 Liège, Belgium
art ic l e i nf o
a b s t r a c t
Article history:
Received 25 April 2013
Received in revised form
8 November 2013
Accepted 9 November 2013
Available online 21 November 2013
Ethnopharmacological relevance: Cymbopogon species are largely used in folk medicine for the treatment
of many diseases some of which related to parasitical diseases as fevers and headaches. As part of our
research on antiparasitic essential oils from Beninese plants, we decided to evaluate the in vitro
antiplasmodial and antitrypanosomal activities of essential oils of four Cymbopogon species used in
traditional medicine as well as their cytotoxicity.
Materials and methods: The essential oils of four Cymbopogon species Cymbopogon citratus (I),
Cymbopogon giganteus (II), Cymbopogon nardus (III) and Cymbopogon schoenantus (IV) from Benin
obtained by hydrodistillation were analysed by GC/MS and GC/FID and were tested in vitro against
Trypanosoma brucei brucei and Plasmodium falciparum respectively for antitrypanosomal and antiplasmodial activities. Cytotoxicity was evaluated in vitro against Chinese Hamster Ovary (CHO) cells and the
human non cancer fibroblast cell line (WI38) through MTT assay to evaluate the selectivity.
Results: All tested oils showed a strong antitrypanosomal activity with a good selectivity. Sample II was
the most active against Trypanosoma brucei brucei and could be considered as a good candidate. It was
less active against Plasmodium falciparum. Samples II, III and IV had low or no cytotoxicity, but the
essential oil of Cymbopogon citratus (I), was toxic against CHO cells and moderately toxic against WI38
cells and needs further toxicological studies. Sample I (29 compounds) was characterised by the presence
as main constituents of geranial, neral, β-pinene and cis-geraniol; sample II (53 compounds) by trans-pmentha-1(7),8-dien-2-ol, trans-carveol, trans-p-mentha-2,8-dienol, cis-p-mentha-2,8-dienol, cis-pmentha-1(7),8-dien-2-ol, limonene, cis-carveol and cis-carvone; sample III (28 compounds) by βcitronellal, nerol, β-citronellol, elemol and limonene and sample IV (41 compounds) by piperitone,
( þ)-2-carene, limonene, elemol and β-eudesmol.
Conclusions: Our study shows that essential oils of Cymbopogon genus can be a good source of
antitrypanosomal agents. This is the first report on the activity of these essential oils against
Trypanosoma brucei brucei, Plasmodium falciparum and analysis of their cytotoxicity.
& 2013 Elsevier Ireland Ltd. All rights reserved.
Keywords:
Cymbopogon species
Essential oils
Chemical composition
Antitrypanosomal activity
Antiplasmodial activity
Cytotoxicity
☆
Chemical compounds studied in this article.
1. Introduction
β-Myrcene (PubChem CID: 31253); Limonene (PubChem CID: 22311); β-Citronellal
(PubChem CID: 7794); Geranial (PubChem CID: 638011); Neral (PubChem CID:
643779); β-Pinene (PubChem CID: 14896); Piperitone (PubChem CID: 6987);
( þ)-2-Carene (PubChem CID: 78249); cis-p-Mentha-1(7),8-dien-2-ol (PubChem
CID: 6429040); Nerol (PubChem CID: 643820).
n
Corresponding author. Tel.: þ 32 2 764 72 54; fax: þ 32 2 764 72 93.
E-mail address: joelle.leclercq@uclouvain.be (J. Quetin-Leclercq).
0378-8741/$ - see front matter & 2013 Elsevier Ireland Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.jep.2013.11.027
Aromatic plants are used since ancient times for their medicinal properties (Bakkali et al., 2008). Essential oils may be used as
alternatives or adjuvants to current antiparasitic therapies and the
emergence of parasites resistant to current chemotherapies highlights the importance of plant essential oils as potential novel
S. Kpoviessi et al. / Journal of Ethnopharmacology 151 (2014) 652–659
antiparasitic agents (Anthony et al., 2005; Moon et al., 2006;
Nibret and Wink, 2010; Cheikh-Ali et al., 2011; Monzote et al.,
2011; Palmeira-de-Oliveira et al., 2012).
Cymbopogon species are commonly used in folk medicine for
the treatment of many diseases. Cymbopogon citratus is used for
the treatment of nervous and gastrointestinal disturbances, and as
an antispasmodic, analgesic, anti-inflammatory, anti-pyretic,
diuretic and sedative (Santin et al., 2009). Decoctions of the leaves
and flowers of Cymbopogon giganteus are used as an effective
treatment against skin disorders, conjunctiva, headaches and
hepatitis (Adjanohoun et al., 1979; Adjanohoun and Aké Assi,
1979, 1985). Cymbopogon nardus is used for cooking, perfumery,
rheumatism and in the treatment of fevers, intestinal parasites and
of digestive and menstrual problems (Konwar and Gohain, 1999;
Abena et al., 2007). Cymbopogon schoenathus is used as an
embrocation, a diuretic, an insecticide, an aphrodisiac, for fever,
snake-bite and for the treatment of rheumatism. The smoke from
the burning grass is said to dispel temporary maniacal symptoms
(IUCN, 2005, Khadri et al., 2010). Essential oils of these species are
known for antimicrobial, antifungal, antioxidant, analgesic, antinociceptive, neurobehavioral and insecticidal properties (Bassolé
et al., 2011; Innsan et al., 2011, Khadri et al., 2010; Abena et al.,
2007; Jirovetz et al. 2007; de Billerbeck et al., 2001; Viana et al.,
2000; Onawunmia et al., 1984) and as repellent against mosquitos, the major vector of malaria (Nonviho et al., 2010;
Samarasekera et al., 2006; Tyagi et al., 1998). Their direct
activity against Trypanosoma brucei and Plasmodium falciparum
was not very documented excepted for essential oil from
Cymbopogon nardus of Malaysia whose in vitro antitrypanosomal activity was recently reported by Muhd Haffiz et al. (2013).
Furthermore, they are used in traditional medicine for the
treatment of symptoms given by malaria or sleeping sickness
(as fevers, headaches,…). So it seemed interesting to study the
antiplasmodial and antitrypanosomal activities of these essential oils and its components.
Trypanosoma brucei is the parasite responsible for human
African trypanosomiasis or sleeping sickness, an illness affecting
300,000–500,000 people, while up to 60 million people in 36
countries are at risk of contracting the disease (World Health
Organisation (WHO), 2002). This parasite is transmitted by the bite
of infected tsetse flies of the genus Glossina.
Malaria is also a disease caused by a protozoan parasite of
Plasmodium species and still remains a major public health
problem in the world. Five hundred million people are exposed
to this disease, with an annual death rate that the World Health
Organisation (WHO/World Health Statistic, 2011) estimates to
more than 800,000 people in 2009.
These two parasitic diseases are the cause of considerable
mortality and morbidity throughout the world (WHO/World
Health Statistic, 2011) and parasites develop resistance to most
of the drugs used. Some of these drugs need a long course
parenteral administration, show toxicity and a variable efficacy
between strains or species. These reasons led to the search for new
antitrypanosomal and antiplasmodial compounds and it is known
that plants used in traditional medicine are a source of new leads
with a new mechanism of action (Hoet et al., 2004, Bero et al.,
2011).
The present study investigates the in vitro antitrypanosomal
and antiplasmodial activity of essential oils from four plants of
Cymbopogon genus used in traditional medicine in Benin. Oils
from fresh leaves of each plant were prepared and analysed by
GC/FID and GC/MS. They were evaluated for their antitrypanosomal and antiplasmodial activities and their selectivity
was assessed by analysing their cytotoxicity against Chinese
Hamster Ovary cells (CHO) and a human non cancer fibroblast
cell line (WI38).
653
2. Materials and methods
2.1. Plant material
Fresh leaves of Cymbopogon citratus (DC) Stapf, Cymbopogon
giganteus (Hochst.) Chiov., Cymbopogon nardius (L.) Rendle and
Cymbopogon schoenantus (L.) Spreng. (Poaceae) were collected in
March 2011, from the Botanical Garden of the Abomey-Calavi
University. Voucher specimens (nos. AA6387, AA6388, AA6389
and 6390/HNB respectively) of these leaves were conserved at the
University of Abomey-Calavi Herbarium.
2.2. Chemicals and drugs
DMEM and Ham's-F12 culture media were purchased from Life
technologies corporation (Grand Island, NY 14072, USA); Dulbecco's Phosphate Buffered Saline (DPBS 1 ) from Invitrogen (Grand
Island, NY 14072, USA); tetrazolium salt (3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium-bromide) (MTT), (S)-( þ)-camptothecin, suramine, chloroquine, artemisinin, dimethyl sulfoxide
(DMSO), α-pinene, β-pinene, camphene, p-cymene, myrcene,
α-terpinene, γ-terpinene,1,8-cineol, terpinolene, borneol, citronellyl acetate, terpine-4-ol, α-terpineol, geraniol, verbenone, carvacrol, thymol, bornyl acetate, α-copaene, β-caryophyllene,
fenchone, thujone, trans-pinocarveol, trans-verbenol, lavandulol,
myrtenal, transcarveol, carvone, aromadendrene, allo-aromadendrene, γ-gurjunene, cis-ocimene, camphor and n-alkanes “C7–C28”
were obtained from Sigma-Aldrich (Steinhein, Germany), Acros
Organics (New jersey, USA), and Fluka Chemie (Buchs, Switzerland); α-thujene, sabinene, γ-3-carene, limonene, linalool, αhumulene, cis-pinane, α-phellandrene, p-cymenene, myrtenyl
acetate and valencene were purchased from extrasynthese (Genay,
France). All compounds were of analytical standard grade. TerButyl methyl ether (TBME) was an analytical grade solvent
purchased from Fluka Chemie, and anhydrous Na2SO4 was of
analytical reagent grade from UCB (Bruxelles, Belgium).
2.3. Isolation of essential oils
Five hundred grams (500 g) of fresh leaves were steam distillated for 3 h in a modified Clevenger-type apparatus (Bruneton,
1993). The extraction was carried out in triplicate. The oils were
preserved in a sealed vial at 4 1C. The essential oil yields were
calculated based on the fresh plant material.
2.4. Chemical analysis of essential oils
2.4.1. GC/FID and GC/MS analysis
The GC/FID analysis was carried out on a FOCUS GC (Thermo
Finigan; Milan, Italy) using the following operating conditions: HP
5MS column (30 m 0.25 mm, film thickness: 0.25 μm) (J&W
Scientific Column of Agilent Technologies, No. US167072Ã, USA);
injection mode: splitless; injection volume: 1 mL (TBME solution);
split flow: 10 mL/min; splitless time: 0.80 min; injector temperature: 260 1C; oven temperature was programmed as following:
50–250 1C at 6 1C/min and held at 250 1C for 5 min; the carrier gas
was helium with a constant flow of 1.2 mL/min; FID detector
temperature was: 260 1C. The data were recorded and treated with
the ChromCard software.
The GC/MS analysis was carried out using a TRACE GC 2000
series (Thermo-Quest, Rodano, Italy), equipped with an autosampler AS2000 Thermo-Quest. The GC system was interfaced to
a Trace MS mass spectrometer (ThermoQuest) operating in the
electronic impact mode at 70 eV. HP 5 MS column (30 m
0.25 mm, film thickness: 0.25 μm) was used in the same operating
conditions as above. The coupling temperature of the GC was
654
S. Kpoviessi et al. / Journal of Ethnopharmacology 151 (2014) 652–659
260 1C and the temperature of the source of the electrons was
260 1C. The data were recorded and analysed with the Xcalibur
1.1 software (ThermoQuest).
in 96-well microtiter plates. The parasitaemia and the haematocrit
were 2% and 1%, respectively. All tests were performed in triplicate.
2.7. In vitro test for antitrypanosomal activity
2.4.2. Identification of oil components
Individual components of the volatile oils were identified by
computer matching against commercial EI-MS spectra library
(NIST, 1998; Adams, 1995), home-made mass spectra library
obtained from pure substances and components of known oils
(Kpoviessi et al., 2011). These identifications were supported by
comparison of the GC retention times of a series of n-alkanes “C7–
C28” mixture on a non-polar column (Kovats indices (KI))
(VanDenDool and Kratz, 1963). These indices calculated were in
agreement with those reported by Adams (1995). For several
compounds, comparison of data and retention times with those
of authentic reference standards further confirmed the identifications. Quantification (expressed as percentages) was carried out by
the normalisation procedure using peak areas obtained by FID.
Values are expressed as mean 7standard deviation (n ¼3).
2.5. Parasites, cell lines and media
Trypanosoma brucei brucei strain 427 (Molteno Institute in
Cambridge, UK) bloodstream forms were cultured in vitro in
HMI9 medium containing 10% heat-inactivated foetal bovine
serum (Hirumi and Hirumi, 1994).
Plasmodium falciparum chloroquine-sensitive strain 3D7 (from
Prof. Grellier of Museum d'Histoire Naturelle, Paris, France) asexual erythrocytic stages were cultivated continuously in vitro
according to the procedure described by Trager and Jensen
(1976) at 37 1C and under an atmosphere of 5% CO2, 5% O2 and
90% N2. The host cells were human red blood cells (A or O Rhþ).
The culture medium was RPMI 1640 (Gibco) containing 32 mM
NaHCO3, 25 mM HEPES and 2.05 mM L-glutamine. The medium
was supplemented with 1.76 g/L glucose (Sigma-Aldrich), 44 mg/
mL hypoxanthin (Sigma-Aldrich), 100 mg/L gentamycin (Gibco)
and 10% human pooled serum (A or O Rhþ ). Parasites were
subcultured every 3–4 days with initial conditions of 0.5% parasitaemia and 1% haematocrit.
The macrophage-like cell line, CHO Chinese Hamster Ovary
cells (ATCC no. CCL-61, batch 4765275), were cultivated in vitro in
Ham's-F12 Nutrient Mixture 21765 medium (Gibco) containing
2 mM L-glutamine supplemented with 10% heat-inactivated foetal
bovine serum (Gibco), penicillin–streptomycin (100 UI/mL–100 μg/
mL) and fungizone (ampotericine D 250 UG/mL). The human non
cancer fibroblast cell line, WI38 (ATCC no. CCL-75 from LGC Standards) was cultivated in vitro in DMEM medium (Gibco) containing
4 mM L-glutamine, 1 mM sodium pyruvate supplemented with 10%
heat-inactivated foetal bovine serum (Gibco), penicillin–streptomycin
(100 UI/mL–100 μg/mL) and fungizone (amphotericin D 250 UG/mL).
2.6. In vitro test for antiplasmodial activity
Parasite viability was measured using parasite lactate dehydrogenase (pLDH) activity according to the method described by Makler et al.
(1993). The in vitro test was performed as described by Murebwayire
et al. (2008). Chloroquine (Sigma) or artemisinin (Sigma) were used as
positive controls in all experiments with an initial concentration of
100 ng/mL. First stock solutions of essential oils and pure compounds
were prepared in DMSO at 20 mg/mL. The solutions were further
diluted in medium to give 2 mg/mL stock solutions. The highest
concentration of solvent to which the parasites were exposed was
1%, which was shown to have no measurable effect on parasite
viability. Essential oils were tested in eight serial threefold dilutions
(final concentration rang: 200–0.09 μg/mL, two wells/concentration)
The in vitro test was performed as described by Hoet et al.
(2004). Suramine (a commercial antitrypanosomal drug, MP
Biomedicals, Eschwege, Germany) was used as positive control in
all experiments with an initial concentration of 1 μg/mL. First
stock solutions of essential oils and compounds were prepared in
DMSO at 20 mg/mL. The solutions were further diluted in medium
to give 0.2 mg/mL stock solutions. Essential oils and compounds
were tested in eight serial threefold dilutions (final concentration
range: 100–0.05 μg/mL, two wells/concentration) in 96-well
microtiter plates. All tests were performed in triplicate.
2.8. Cytotoxicity assay
The cytotoxicity of the oils against CHO and WI38 cells was
evaluated as described by Stevigny et al. (2002), using the tetrazolium salt MTT (3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (Sigma)) colorimetric method based on the
cleavage of the reagent by dehydrogenases in viable cells
(Mosmann, 1983). Camptothecin (Sigma) was used as positive
cytotoxic reference compound. Stock solutions of compounds
and essential oils were prepared in DMSO at 10 mg/mL. The
solutions were further diluted in medium with final concentrations of 50-1.56 μg/mL (four wells/concentration). The highest
concentration of solvent to which the cells were exposed was 1%,
which was shown to be non-toxic. Each oil was tested in six serial
twofold dilutions in 96-well microtitre plates. All experiments
were made at least in duplicate.
2.9. Statistical analysis
Student's t-test was used to test the significance of differences
between results obtained for different samples, and between
results for samples and controls (GraphPad Prism 4.0; GraphPad
Software Inc., San Diego, USA). Statistical significance was set at
Po 0.05.
3. Results and discussion
3.1. Chemical composition of the essential oils
The oils extracted from fresh leaves of Cymbopogon citratus (I),
Cymbopogon giganteus (II), Cymbopogon nardus (III) and Cymbopogon
schoenantus (IV) collected in the same place and in the same time,
were obtained with different yields (w/w) (Table 1). This may be
explained by the difference between species. Moreover, these yields
were less than those described by Nonviho et al. (2010) on dried
leaves of three of these plants (I, II and IV), but they were calculated
on the dry material (Bourkhiss et al., 2009; Nebie et al., 2011). A total
of 29 (I), 53 (II), 28 (III) and 41 (IV) compounds, representing
respectively 98.1% (I), 98.6% (II), 98.5% (III) and 98.6% (IV) of the
hydrodistillate, were identified (Table 1). The oils were characterised
by two major chemical groups: monoterpenes and sesquiterpenes,
with a high amount of oxygenated monoterpenes in all studied oils
(Table 2) followed by hydrocarbon monoterpenes in IV, I and II; and
by oxygenated sesquiterpenes in III (Table 2). Almost all constituents
of I and II were monoterpenes while III and IV contained
monoterpenes with sesquiterpenes (Table 2). Non terpenic compounds were mainly identified in II, where 4,4-dimethyl androst-5en-3-one was the major component of this class (Table 1). The
sample I (29 compounds, 98.1%) obtained from Cymbopogon citratus
655
S. Kpoviessi et al. / Journal of Ethnopharmacology 151 (2014) 652–659
Table 1
Chemical composition and yield of essential oils from Cymbopogon species (mean 7standard deviation, n¼ 3).
No.
Compoundsa
KIb
I
II
III
IV
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
α-Pinenec,f,i
Camphenec,f,i
β-Myrcenec,f,i
β-Pinenec,f,i
( þ )-2-Carenec,f,i
α-Phellandrenec,f,i
p-Cymenec,f,i
Limonenec,f,i
(Z)-β-ocimenec,f,i
(E)-β-ocimenec,f,i
Melonalc,g
α-Terpinolenec,f,i
Thujolc,g,i
Fenchone-Dc,g
Myrcenolc,g,i
β-Linaloolc,g,i
trans-3(10)-caren-2-olc,g
p-Mentha-1,3,8-trienolc,g
trans-p-mentha-2,8-dienolc,g
cis-p-mentha-2,8-dienolc,g
Isopulegolc,g
4-Isopropylidene-cyclohexanole,g
α-Phellandren-8-olc,g,i
trans-2-caren-4-olc,g,i
cis-α-terpineolc,g,i
trans-p-mentha-1(7),8-dien-2-olc,g
β-Citronellalc,g,i
cis-verbenolc,g
trans-carane, 4,5-epoxy-c,g
cis-p-mentha-1(7),8-dien-2-olc,g
trans-piperitolc,g,i
p-Menth-1-en-9-alc,g
cis-carveolc,g,i
7-Methyl-3-methylene-6-octen-1-ole,g
β-Citronellolc,g,i
trans-carveolc,g
cis-carvonec,g,i
Neralc,g,i
Isoamyl hexanoatee,g
trans-3-caren-2-olc,g
cis-geraniolc,g,i
Perillalc,g
Nerolc,g,i
Piperitonec,g,i
p-Mentha-1(7),8(10)-dien-9-olc,g
1-Methyl-2-decalonec,g
Limonene dioxidec,g
2-Caren-10-alc,g
Geranialc,g,i
Piperitone oxidec,g
Exo-2-hydroxycineole acetatec,g
Nopolc,g
β-Bourbonened,f
Geranyl acetatec,g
β-Elemened,f,i
2-Undecanoned,g
3-Oxo-α-ionold,g
β-Caryophyllened,f,i
Neric acidc,g
Isoamyl caprylated,g
α-Humulened,f,i
β-Cubebened,f
Geranic acidc,g
α-Himachalened,f
Germacrene-Dd,f,i
β-Eudesmened,f,i
τ-Gurjunened,f
α-Muurolened,f
Seychellened,f
τ-Muurolened,f
α-Bergamotened,f
δ-Cadinened,f,i
Elemold,g,i
Geranyl butyratec,g
Cubenold,g,i
949
963
993
996
1005
1017
1023
1028
1032
1042
1045
1055
1070
1090
1092
1101
1110
1111
1120
1133
1142
1146
1161
1171
1173
1181
1192
1199
1201
1206
1211
1215
1227
1230
1244
1246
1267
1268
1278
1288
1291
1292
1294
1296
1298
1304
1315
1320
1328
1331
1335
1338
1340
1344
1353
1368
1392
1394
1423
1427
1443
1454
1467
1470
1477
1483
1493
1499
1505
1514
1521
1523
1556
1568
1579
t
–
–
10.1 70.04
–
–
0.5 70.00
–
0.4 70.00
0.2 70.00
–
0.2 70.00
–
–
0.4 70.00
0.9 70.00
0.17 0.00
–
–
0.17 0.00
–
–
0.5 70.00
–
–
–
0.4 70.00
1.77 0.01
–
–
–
–
–
–
0.4 70.00
–
–
35.57 0.15
–
–
4.3 70.02
–
–
–
0.17 0.00
–
–
–
39.5 70.00
–
–
0.4 70.00
0.5 70.00
1.07 0.00
–
0.17 0.00
–
0.2 70.00
0.17 0.00
–
–
–
0.17 0.00
–
–
–
0.17 0.00
–
–
–
0.17 0.00
–
–
–
–
–
–
t
–
0.47 0.00
–
–
8.37 0.08
–
–
t
0.1 70.00
0.1 70.00
0.37 0.00
–
0.1 70.00
–
0.27 0.00
15.5 7 0.15
11.3 7 0.03
–
0.1 70.00
0.87 0.01
–
t
18.3 70.17
t
–
1.57 0.01
8.97 0.08
–
0.27 0.00
7.37 0.07
–
–
17.47 0.16
3.47 0.03
–
0.37 0.00
0.27 0.00
–
0.57 0.01
–
0.1 70.00
0.1 70.01
0.1 70.00
0.1 70.00
–
–
0.1 70.00
0.1 70.00
t
–
0.1 70.00
t
–
0.1 70.03
t
–
0.27 0.00
–
–
–
t
–
t
–
t
–
t
–
–
–
–
–
–
–
0.27 0.00
–
–
–
–
2.27 0.02
–
–
0.27 0.00
–
–
–
–
0.47 0.00
–
–
–
–
0.27 0.00
–
–
–
–
–
35.9 7 0.34
–
–
–
–
–
–
–
11.6 7 0.11
–
–
0.47 0.00
–
–
–
–
24.3 7 0.23
–
–
–
–
–
0.67 0.01
–
–
–
–
1.37 0.01
1.97 0.02
–
–
0.1 70.00
–
–
0.1 70.00
0.1 70.00
–
–
1.57 0.01
–
0.27 0.00
0.27 0.00
0.27 0.00
0.47 0.00
–
1.17 0.01
9.07 0.08
–
1.87 0.02
0.1 70.00
0.1 70.00
0.27 0.00
–
13.0 7 0.20
0.27 0.00
–
6.47 0.10
–
0.77 0.01
–
0.27 0.00
–
0.37 0.01
–
–
–
–
1.8 7 0.03
1.3 7 0.02
–
–
0.47 0.01
0.1 70.00
–
0.37 0.00
–
–
–
–
0.57 0.01
–
–
0.27 0.00
–
–
–
–
–
–
–
–
–
60.37 0.92
–
–
–
0.1 70.00
–
–
–
–
0.1 70.00
–
0.47 0.01
–
–
0.87 0.01
–
–
0.1 70.00
–
–
0.1 70.00
0.1 70.00
0.1 70.00
0.1 70.00
t
0.1 70.00
0.1 70.00
–
0.27 0.00
4.97 0.08
0.47 0.01
t
656
S. Kpoviessi et al. / Journal of Ethnopharmacology 151 (2014) 652–659
Table 1 (continued )
No.
Compoundsa
KIb
I
II
III
IV
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
β-Caryophyllene oxided,g
Hedycaryold,g
Ledold,g,i
Eudesm-7(11)-en-4-old,g
Phenylethyl caproatee,g
Guaiold,g
τ-Eudesmold,g
τ-Cadinold,g,i
β-Eudesmold,g,i
α-Cadinold,g,i
Isoaromadendrene epoxided,g
(Z,E)-farnesold,g
Geranyl caproatec,g
( )-Spathulenold,g
Ledene alcohold,g
Phenylethyl octanoatee,g
4,4-Dimethylandrost-5-en-3-onee,g
Bolasteronee,g
Norethindronee,g
1585
1610
1615
1617
1619
1620
1630
1639
1648
1650
1661
1699
1748
1779
1809
1888
2184
2209
2336
0.17 0.00
–
–
0.17 0.00
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
0.1 70.00
–
–
–
0.1 70.00
–
–
–
t
–
t
t
0.1 70.03
t
t
0.1 70.01
1.7 7 0.02
0.27 0.00
0.1 70.04
–
–
0.6 7 0.01
–
–
–
0.6 7 0.01
1.17 0.01
–
2.0 7 0.02
–
0.2 7 0.00
–
–
–
–
–
–
–
0.4 7 0.01
t
–
–
–
0.17 0.00
1.17 0.02
0.3 7 0.00
3.17 0.05
–
0.17 0.00
0.17 0.00
–
–
–
–
–
–
–
Total identified
98.17 0.41
98.67 0.97
98.5 7 0.92
98.6 7 0.52
h
0.717 0.02
0.657 0.02
1.067 0.10
1.88 7 0.12
Yield (%)
a
Compounds listed in order of elution from HP-5 MS column.
Kovats indices (KI) on HP-5 MS column; I ¼Essential oil from Cymbopogon citratus; II ¼essential oil from
Cymbopogon giganteus; III¼ essential oil from Cymbopogon nardus; IV ¼essential oil from Cymbopogon
schoenantus; t ¼traces (inferior or equal to 0.05%); and ( ) ¼ absence or not detected.
c
Monoterpenes.
d
Sesquiterpenes.
e
Non-terpenes.
f
Hydrocarbons.
g
Oxygenetad.
h
Yield calculated based on the fresh plant material.
i
Comparison of data with reference standard.
b
Table 2
Chemical groups in essential oils from Cymbopogon species (mean 7standard deviation, n¼3).
No.
Chemical groups
I
II
III
IV
1
2
3
4
5
6
7
Hydrocarbon monoterpenes
Oxygenated monoterpenes
Monoterpenes
Hydrocarbon sesquiterpenes
Oxygenated sesquiterpenes
Sesquiterpenes
Others
11.4 7 0.04
85.5 7 0.35
96.97 0.39
0.4 7 0.00
0.2 7 0.00
0.67 0.00
0.67 0.04
8.8 70.08
86.7 70.73
95.57 0.81
t
0.3 70.06
0.37 0.06
2.87 0.07
2.4 70.02
74.9 7 0.7
77.37 0.09
5.8 70.04
15.3 7 0.15
21.1 70.19
–
20.9 7 0.31
65.5 7 1.01
86.47 1.32
2.2 7 0.02
10.0 7 0.16
12.27 0.18
0.37 0.00
I¼ Essential oil of Cymbopogon citratus, II¼ essential oil of Cymbopogon giganteus, III¼essential oil of Cymbopogon nardus, IV¼ essential oil of Cymbopogon schoenantus, (
absence or not detected, and t¼ traces (inferior or equal to 0.05%).
was characterised by the presence as main constituents of geranial,
neral, β-pinene, cis-geraniol, cis-verbenol and geranyl acetate
(Table 1). The mixture of geranial and neral, two geometrical isomers
constituting of citral, accounts for about 75% of the total of oil I
(Table 1). Sakirigui et al. (2011) obtained 70.13% of citral, Nonviho
et al. (2010) 74% and Blanco et al. (2009) 77% in Cymbopogon citratus
oil. The sample II (53 compounds, 98.6%) obtained from Cymbopogon
giganteus was characterised by the presence as major constituents of
trans-p-mentha-1(7),8-dien-2-ol, trans-carveol, trans-p-mentha-2,8dienol, cis-p-mentha-2,8-dienol, cis-p-mentha-1(7),8-dien-2-ol, limonene, cis-carveol, cis-carvone, 4,4-dimethylandrost-5-en-3-one and
trans-carane-4,5-epoxy (Table 1). Its composition, except for limonene, approached that found in leaves from Togo (Nyamador et al.,
2010). The sample III (28 compounds, 98.5%) obtained from Cymbopogon nadus was characterised by a high concentration of βcitronellal, nerol, β-citronellol, elemol, limonene, α-cadinol, β-elemene, cubenol, germacrene-D, geranyl acetate, δ-cadinene and τcadinol (Table 1). These results seem similar to those of Oliveira et al.
)¼
(2011) that identified in the Brazilian species 34.61% of citronellal
followed by 23.18% of geraniol and 12.10% of citronellol. The sample
IV (41 compounds, 98.6%) obtained from Cymbopogon schoenantus
showed the presence as main constituents of piperitone, (þ)-2carene, limonene, elemol, β-eudesmol, trans-p-mentha-2,8-dienol,
cis-p-mentha-2,8-dienol and τ-eudesmol (Table 1). This composition
was different from that described by Nonviho et al. (2010) which
found 68% of piperitone in a sample from Akogbato (Benin) but was
close to the results reported by Ayedoun et al. (1997) in a sample
from Bassila (Benin). The major components represented over 90% of
the studied oils. The concentrations of all the other constituents were
less than 1.2%. Each oil was thus characterised by known compounds
with percentages sometimes different from those described in the
literature (Nonviho et al., 2010; Abena et al., 2007, Alitonou et al.,
2006; Sidibé et al., 2001; Shahi and Tava, 1993). This variation can be
due to the influence of the moment or the place of harvest in the
chemical composition of these oils (Singh et al., 1994; Boruah et al.,
1995; Kpoviessi et al., 2011; Kpadonou Kpoviessi et al., 2012).
657
S. Kpoviessi et al. / Journal of Ethnopharmacology 151 (2014) 652–659
Table 3
In vitro antitrypanosomal and antiplasmodial activity, cytotoxicity and selectivity index of essential oils from Cymbopogon species and some of their major components.
Samples
I
II
III
IV
Myrcene
R( þ )-limonene
Citral
Citronellal
Nerol
β-Citronellol
β-Pinene
6-Acetoxy-pmentha-1,8diene
p-Cymene
Campthotecin
Suramine
Chloroquine
Artemisinin
Cytotoxicity (IC50, μg/
mL) average7 standard
deviation
Antitrypanosomal activity Tbb (IC50, μg/mL)
average7 standard deviation
Antiplasmodial activity Pf (IC50, μg/mL)
average7 standard deviation
CHO
WI38
10.63 7 0.72
450
450
450
450
450
20.62 7 1.59
450
450
450
450
450
39.777 3.31
4 50
4 50
4 50
4 50
4 50
39.487 1.59
4 50
4 50
4 50
4 50
4 50
1.83 7 0.13b
0.25 70.11a
5.717 1.40c
2.107 0.89b
2.247 0.27b
4.247 2.27c
5.98 70.54c
2.76 7 1.55b
4100
6.45 74..86c
47.377 15.65e
28.82 72.91d
47.977 13.09c
11.22 7 5.35b
52.61 74.79c
43.15 713.19c
nd
nd
nd
nd
nd
nd
nd
nd
450
0.747 0.09
nd
nd
nd
4 50
0.44 70.12
nd
nd
nd
76.32 7 13.27f
nd
0.117 0.02a
nd
nd
nd
nd
0.02 7 0.01a
0.01 70.001a
τ
Selectivity indices
WI38/
Tbb
WI38/
3D7
3D7/
Tbb
21.73
4200
48.76
423.81
411.76
48.94
4.01
47.41
o0.5
41.53
41.06
44.64
0.93
44.46
40.95
41.16
26.21
3.14
9.21
20.55
I ¼Essential oil from Cymbopogon citratus, II ¼ essential oil from Cymbopogon giganteus, III¼ essential oil from Cymbopogon nardus, IV¼ essential oil from Cymbopogon
schoenantus, WI38 ¼human normal fibroblast cells, CHO ¼ Chinese Hamster Ovary cells, nd¼ not determined, Tbb ¼ Trypanosoma brucei brucei, 3D7 ¼chloroquine-sensitive
strain of Plasmodium falciparum, and IC50 ¼ sample concentration providing 50% death of cells or parasites. τSelectivity index ¼IC50 (WI38)/IC50 (Tbb or 3D7). Data in the same
column followed by different letters (a,b,c,…) are statistically different by Student's t-test (Po 0.05). Values are means7 standard deviation of three separate experiments.
3.2. Antitrypanosomal, antiplasmodial activities and cytotoxicity
All the studied oils were tested in vitro for their antitrypanosomal and antiplasmodial activities respectively on Trypanosoma
brucei brucei and Plasmodium falciparum 3D7 and their cytotoxicity
against WI38 and CHO cells. Results are summarised in Table 3. All
oils showed a stronger effect against Trypanosoma brucei brucei
with IC50 values r6 μg/mL. These oils were in increased order of
activity. Cymbopogon nardus (III, IC50 ¼ 5.71 71.40 μg/mL), Cymbopogon schoenantus (IV, IC50 ¼2.10 70.89 μg/mL), Cymbopogon
citratus (I, IC50 ¼1.83 7 0.13 μg/mL) and Cymbopogon giganteus
(II, IC50 ¼0.25 7 0.11 μg/mL). The student's t-test showed a highly
significant difference between the activity of II and the other
tested oils. However the activity of the essential oil from Cymbopogon giganteus (II) was not significantly different (P value 4 0.1)
to that of suramine (IC50 ¼0.11 70.02 μg/mL) the standard compound used against this parasite. The selectivity index of the four
tested oils (I ¼21.73; II 4200; III48.75 and IV4 23.81) showed
that II was also the most selective. In vivo studies should be
performed to assess its efficacy on sleeping sickness and determine if the essential oil from Cymbopogon giganteus (II), already
used extensively in traditional medicine, can be recommended for
the treatment of this illness. It will necessary to search for
adequate formulation as LBDDS (lipid based drug delivery systems) (Mu et al., 2013) and to verify the absence of toxicity.
Recently, Muhd Haffiz et al. (2013) reported a different IC50 value
(0.31 70.03 μg/mL) for the essential oil of Cymbopogon nardus
from Malaysia, tested against the BS221 strain of Trypanosoma
brucei brucei. This difference on IC50 value may be due to
differences in the origin and the composition of the essential oil
and in the strain of Trypanosoma brucei brucei. The antitrypanosomal activity of available major compounds of these studied oils
was also evaluated. β-Myrcene (IC50 ¼2.24 μg/mL), citronellal
(IC50 ¼2.76 μg/mL), R(þ)-limonene (IC50 ¼ 4.24 μg/mL), citral
(IC50 ¼5.98 μg/mL) and β-citronellol (IC50 ¼6.45 μg/mL) showed
antitrypanosomal IC50 values near to those of studied oils and can
in part explain their activities. The antitrypanosomal IC50 values of
the other tested major components: 6-acetoxy-p-mentha-1,8diene (IC50 ¼ 28.82 μg/mL), β-pinene (IC50 ¼47.37 μg/mL) and pcymene (IC50 ¼ 76.32 μg/mL); and those of (7)-linalool (39.32 μg/
mL), β-caryophylene (13.78 μg/mL), 1,8-cineole (83.15 μg/mL),
( )-carvone (12.94 μg/mL), piperitone (41.12 μg/mL), ( )-verbenone (30.24 μg/mL), limonene epoxide (22.58 μg/mL) and caryophyllene oxide (17.70 μg/mL) (Hoet et al., 2006; Nibret and Wink,
2010), were higher than 10 μg/mL and could not explain the strong
activity of these oils but synergic effect is possible. Furthermore,
most of the major constituents of II were not available and could
not be tested. Even though sesquiterpenes as artemisinin are good
antiparasitic agents, we note here that the two most active
antitrypanosomal oils only contain trace amounts of sesquiterpenes and are particularly rich in oxygenated monoterpenes
(Table 2). Two of them: trans-p-mentha-1(7),8-dien-2-ol and
trans-carveol are major compounds of II, possessing the best
activities and should be tested to elucidate their contribution to
the antitrypanosomal activity of II.
Concerning the antiplasmodial activity against the chloroquinosensitive strain of Plasmodium falciparum (3D7), we observed that
Cymbopogon giganteus essential oil (II) was the only one which could
be considered as having an interesting activity with an IC50 value
r20 μg/mL, the other oils had a moderate activity (IC50 values
between 21 and 60 μg/mL). With a selectivity index 44.46, the
essential oil Cymbopogon giganteus (II) can also be a good candidate
for bio-guided fractionation to yield a more active fraction against
Plasmodium falciparum. It would also be interesting to test trans-pmentha-1(7),8-dien-2-ol and trans-carveol, the major compounds of
this oil, on Plasmodium. Moreover these results showed the selectivity of the activity of the studied oils on Trypanosoma brucei brucei as
compared to Plasmodium falciparum (SI43 for all studied oils).
The cytotoxicity tests against the Chinese Hamster Ovary
(CHO) cells and the human non cancer fibroblast cell line (WI38)
showed that all tested oils and components had a low cytotoxicity
(IC50 450 μg/mL) (Table 2). The only exception was Cymbopogon
citratus essential oil (I) which was toxic against CHO cells
(IC50 ¼10.63 μg/mL) and moderately toxic against WI38 cells
658
S. Kpoviessi et al. / Journal of Ethnopharmacology 151 (2014) 652–659
(IC50 ¼39.77 μg/mL). The major component of this oil
(citral¼neralþgeranial ¼74%) was also toxic against CHO cells
(IC50 ¼20.62 μg/mL) and moderately toxic against WI38 cells
(IC50 ¼39.48 μg/mL). The second major component (β-pinene¼ 10.10%) was not toxic against these cells (IC50 450 μg/mL).
4. Conclusions
Our study shows that the essential oils of Cymbopogon
citratus (I), Cymbopogon giganteus (II), Cymbopogon nardus (III)
and Cymbopogon schoenantus (IV) from Benin were more active on
Trypanosoma brucei brucei than on Plasmodium falciparum (3D7).
The essential oil of Cymbopogon giganteus (II) already used
extensively in traditional medicine is the most active and could
be interesting for the treatment of sleeping sickness but may also
have some interest on Plasmodium. These oils had a low cytotoxicity except Cymbopogon citratus essential oil (I) which was toxic
against CHO cells and moderately toxic against WI38 cells. Its
major component (citral¼neralþgeranial) was also toxic against
CHO cells and moderately toxic against WI38 cells. Cymbopogon
citratus already largely used in folk medicine and cooking should
need further research on its toxicity and the population sensitised
about it. This is the first report on the activities of these essential
oils against Trypanosoma brucei brucei, Plasmodium falciparum and
their cytotoxicity.
Author agreement
All authors have made substantial contributions and final
approval of the conceptions, drafting, and final version.
Acknowledgements
The authors are grateful to Ramazan Colak for skillful technical
assistance. We would also like to thank the Malaria's team from
University of Liege for cell lines and continuous culture. This work
was supported by the CUD-PIC (Commission Universitaire pour le
Développement – Projet Inter universitaire Ciblé), CIUF (Coopération Institutionnelle Universitaire Francophone) through a
financement given to S. Kpoviessi, the Belgian National Fund for
Scientific Research (FNRS) (T.0190.13) and the Faculty of Pharmacy
and Biomedical Sciences of UCL.
References
Abena, A.A., Gbenou, J.D., Yayi, E., Moudachirou, M., Ongoka, R.P., Ouamba, J.M.,
Silou, T., 2007. Comparative chemical and analgesic properties of essential oils
of Cymbopogon nardus (L.) rendle of Benin and Congo. Afr. J. Tradit. Complement. Altern. Med. 4 (2), 267–272.
Adams, R.P., 1995. Identification of Essential Oil Components by Gas Chromatography and Mass Spectrometry. Allured, Carol Stream, IL, USA, pp. 57–332.
Adjanohoun, E.J., Aké Assi, L., 1979. Contribution au recensement des plantes
médicinales de Côte d'Ivoire. Centre national floristique, Abidjan.
Adjanohoun, E.J., Aké Assi, L., 1985. Contribution aux études ethnobotaniques et
floristiques au Mali, fifth ed. Agence de coopération culturelle et technique,
Paris.
Adjanohoun, E.J., Aké Assi, L., Floret, J.J., Guinko, S., Koumaré, M., Ahyi, A.M.R.,
Raynal, J., 1979. Médecine traditionnelle et pharmacopée Contribution aux
études ethnobotaniques et floristiques au Mali, second ed. Agence de coopération culturelle et technique, Paris.
Alitonou, G.A., Avlessi, F., Sohounhloue, D.K., Agnaniet, H., Bessiere, J.-M., Menut, C.,
2006. Investigations on the essential oil of Cymbopogon giganteus from Benin
for its potential use as an anti-inflammatory agent. Int. J. Aromather. 16 (1),
37–41.
Anthony, J.P., Fyfe, L., Smith, H., 2005. Plant active components-a resource for
antiparasitic agents? Trends Parasitol. 21 (10), 462–468.
Ayedoun, M.A., Sohounhloue, D.K., Menut, C., Lamaty, G., Bessiere, J.M., 1997.
Composition chimique des huiles essentielles de deux espèces de Cymbopogon
du Bénin exploitables industriellemnt. Bull. Afr. Bioresour.-Energie-Dév.Environ., 4–6.
Bakkali, F., Averbeck, S., Averbeck, D., Idaomar, M., 2008. Biological effects of
essential oils—a review. Food Chem. Toxicol. 46, 446–475.
Bassolé, I.H.N., Lamien-Meda, A., Bayala, B., Obame, L.C., Ilboudo, A.J., Franz, C.,
Novak, J., Nebié, R.C., Dicko, M.H., 2011. Chemical composition and antimicrobial activity of Cymbopogon citratus and Cymbopogon giganteus essential oils
alone and in combination. Phytomedicine 18, 1070–1074.
Bero, J., Hannaert, V., Chataigné, G., Hérent, M.-F., Quetin-Leclercq, J., 2011. In vitro
antitrypanosomal and antileishmanial activity of plants used in Benin in
traditional medicine and bio guided fractionation of the most active extract.
J. Ethnopharmacol. 137, 998–1002.
Blanco, M.M., Costa, C.A.R.A., Freire, A.O., Santos Jr., J.G., Costa, M., 2009. Neurobehavioral effect of essential oil of Cymbopogon citratus in mice. Phytomedicine
16, 265–270.
Boruah, P., Misra, B.P., Pathak, M.G., Ghosh, A.C., 1995. Dynamics of essential oil of
Cymbopogon citratus (DC) Stapf under rust disease indices. J. Essent. Oil Res. 7
(3), 337–338.
Bourkhiss, M., Hnach, M., Bourkhiss, B., Ouhssine, M., Chaouch, A., Satrani, B., 2009.
Effet de séchage sur la teneur et la composition chimique des huiles essentielles
de Tetraclinis articulata (Vahl) Masters. Agrosolutions 20 (1), 44–48.
Bruneton, J., 1993. Pharmacognosie: Phytochimie, Plantes Médicinales, second ed.
Technique et Documentation-Lavoisier, Paris, pp. 387–404.
Cheikh-Ali, Z., Adiko, M., Bouttier, S., Bories, C., Okpekon, T., Poupon, E., Champy, P.,
2011. Composition, and antimicrobial and remarkable antiprotozoal activities of
the essential oil of rhizomes of Aframomum sceptrum K. Schum. (Zingiberaceae).
Chem. Biodivers. 8 (4), 658–667.
(de) Billerbeck, V.G., Roques, C.G., Bessière, J.-M., Fonvieille, J.-L., Dargent, R., 2001.
Effects of Cymbopogon nardus (L.) W. Watson essential oil on the growth and
morphogenesis of Aspergillus niger. Can. J. Microbiol. 47, 9–17.
Hirumi, H., Hirumi, K., 1994. Axenic culture of African trypanosome bloodstream
forms. Parasitol. Today 10, 80–84.
Hoet, S., Opperdoes, F., Brun, R., Adjakidjé, V., Quetin-Leclercq, J., 2004. In vitro
antitrypanosomal activity of ethnopharmacologically selected Beninese plants.
J. Ethnopharmacol. 91, 37–42.
Hoet, S., Stevigny, C., Herent, M.-F., Quetin-Leclercq, J., 2006. Antitrypanosomal
compounds from the leaf essential oil of Strychnos spinosa. Planta Med. 72,
480–482.
Innsan, M.F.M.F., Shahril, M.H., Samihah, M.S., Asma, O.S., Radzi, S.M., Abd Jalil, A.K.,
Hanina, M.N., 2011. Pharmacodynamic properties of essential oils from Cymbopogon species. Afr. J. Pharm. Pharmacol. 5 (24), 2676–2679.
IUCN, 2005. A guide to medicinal plants in North Africa. ISBN: 2-8317-0893-1,
p. 256.
Jirovetz, L., Buchbauer, G., Eller, G., Ngassoum, B.M., Maponmetsem, P.M., 2007.
Composition and antimicrobial activity of Cymbopogon giganteus (Hochst.)
Chiov. essential flower, leaf and stem oils from Cameroon. J. Essent. Oil Res.
19, 485–489.
Khadri, A., Neffati, M., Smiti, S., Falé, P., Lino, A.R.L., Serralheiro, L.M.L., Araujo, M.E.
M., 2010. Antioxidant, antiacetylcholinesterase and antimicrobial activities of
Cymbopogon schoenanthus L. Spreng (lemon grass) from Tunisia. LWT – Food
Sci. Technol. 43, 331–336.
Konwar, B.K., Gohain, A.K., 1999. Nutritive value of spent citronella grass (Cymbopogon nardus) in cattle. Indian J. Anim. Nutr. 16 (4), 324–325.
Kpadonou Kpoviessi, B.G.H., Yayi Ladekan, E., Kpoviessi, D.S.S., Gbaguidi, F.,
Yehouenou, B., Quetin-Leclercq, J., Figueredo, G., Moudachirou, M., Accrombessi, G.C., 2012. Chemical variation of essential oil constituents of Ocimum
gratissimum L. from Benin, and impact on antimicrobial properties and toxicity
against Artemia salina Leach. Chem. Biodivers. 9 (1), 139–150.
Kpoviessi, D.S.S., Gbaguidi, F.A., Kossouoh, C., Agbani, P., Yayi-Ladekan, E., Sinsin, B.,
Moudachirou, M., Accrombessi, G.C., Quetin-Leclercq, J., 2011. Chemical composition and seasonal variation of essential oil of Sclerocarya birrea (A. Rich.)
Hochst subsp birrea leaves from Benin. J. Med. Plants Res. 5 (18), 4640–4646.
Makler, M.T., Ries, J.M., Williams, J.A., Bancroft, J.E., Piper, R.C., Gibbins, B.L.,
Hinrichs, D.J., 1993. Parasite lactate-dehydrogenase as an assay for Plasmodium
falciparum drug-sensitivity. Am. J. Trop. Med. Hyg. 48, 739–741.
Monzote, L., Nance, M.R., Garcia, M., Scull, R., Setzer, W.N., 2011. Comparative
chemical, cytotoxicity and antileishmanial properties of essential oils from
Chenopodium ambrosioides. Nat. Prod. Commun. 6 (2), 281–286.
Moon, T., Wilkinson, J.M., Cavanagh, H.M.A., 2006. Antiparasitic activity of two
Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and
Hexamita inflate. Parasitolol. Res. 99, 722–728.
Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival:
application to proliferation and cytotoxicity assays. J. Immunol. Methods 65,
55–63.
Mu, H., Holm, R., Müllertz, A., 2013. Lipid-based formulations for oral administration of poorly water-soluble drugs. Int. J. Pharm. 453 (1), 215–224.
Muhd Haffiz, J., Norhayati, I., Getha, K., Nor Azah, M.A., Mohd Ilham, A., Lili Sahira,
H., Roshan Jahn, M.S., Muhd Syamil, A., 2013. Chemical composition and in vitro
antitrypanosomal activity of fractions of essential oil from Cymbopogon nardus
L. Trop. Biomed. 30 (1), 9–14.
Murebwayire, S., Frederich, M., Hannaert, V., Jonville, M.C., Duez, P., 2008.
Antiplasmodial and antitrypanosomal activity of Triclisia sacleuxii (Pierre) Diels.
Phytomedicine 15, 728–733.
National Institute of Standard and Technology/Environemental Protection
Agency/National Institutes Health [NIST/EPA/NIH], 1998. Mass spectral
S. Kpoviessi et al. / Journal of Ethnopharmacology 151 (2014) 652–659
database, Standard reference database no. 1A, version 1.6. NIST/EPA/NIH,
Gaithersburg, MD.
Nebie, R.H.C., Dabire, C., Belanger, A., Nacro, M., Sib, F.S., 2011. Effet du séchage de la
matière végétale sur la composition chimique de l'huile essentielle et l'activité
antioxydante d'extraits d'Ocimum basilicum L. Int. J. Biol. Chem. Sci. 5 (3),
1082–1095.
Nibret, E., Wink, M., 2010. Trypanocidal and antileukaemic effects of the essential
oils of Hagenia abyssinica, Leonotis ocymifolia, Moringa stenopetala, and their
main individual constituents. Phytomedicine 17, 911–920.
Nonviho, G., Wotto, V.D., Noudogbessi, J.-P., Avlessi, F., Akogbeto, M., Sohounhloué, D.C.K.,
2010. Insecticidal activities of essential oils extracted from three species of poaceae
on Anopheles gambiae spp, major vector of malaria. Sci. Study Res. Chem. Chem.
Eng., Biotechnol., Food Ind. 11 (4), 411–420.
Nyamador, W.S., Ketoh, G.K., Amévoin, K., Nuto, Y., Koumaglo, H.K., Glitho, I.A.,
2010. Variation in the susceptibility of two Callosobruchus species to essential
oils. J. Stored Prod. Res. 46, 48–51.
Oliveira, M.M.M., Brugnera, D.F., Cardoso, M.G., Guimarães, L.G.L., Piccoli, R.H., 2011.
Yield, chemical composition and antilisterial activity of essential oils from
Cymbopogon species. Rev. Bras. Plantas Med. 13 (1), 8–16.
Onawunmia, G.O., Yisakb, W.A.B., Ogunlana, E.O., 1984. Antibacterial constituents in
the essential oil of Cymbopogon citratus (dc.) Stapf. J. Ethnopharmacol. 12,
274–286.
Palmeira-de-Oliveira, A., Gaspar, C., Palmeira-de-Oliveira, R., Silva-Dias, A.,
Salgueiro, L., Cavaleiro, C., Pina-Vaz, C., Martinez-de-Oliveira, J., Queiroz, J.A.,
Rodrigues, A.G., 2012. The anti-Candida activity of Thymbra capitata essential
oil: effect upon pre-formed biofilm. J. Ethnopharmacol. 140, 379–383.
Sakirigui, A., Kossouoh, C., Gbaguidi, F., Kpoviessi, S., Fatondji, R.H., Poupaert, J.,
Accrombessi, G.C., 2011. Hemisynthesis and antiparasitic activities on Trypanosoma brucei brucei of thiosemicarbazones of the citral in the essential oil of
Cymbopogon citratus of Benin. J. Soc. Ouest-Afr. Chim. 031, 11–20.
Samarasekera, R., Kalhari, K.S., Weerasinghe, I.S., 2006. Insecticidal activity of
essential oils of Ceylon Cinnamomum and Cymbopogon species against Musca
domestica. J. Essent. Oil Res. 18 (3), 352–354.
659
Santin, M.R., dos Santos, A.O., Nakamura, C.V., Filho, B.P.D., Ferreira, I.C.P.,
Ueda-Nakamura, T., 2009. In vitro activity of the essential oil of Cymbopogon
citratus and its major component (citral) on Leishmania amazonensis. Parasitol.
Res. 05, 1489–1496.
Shahi, A.K., Tava, A., 1993. Essential oil composition of three Cymbopogon species of
Indian Thar Desert. J. Essent. Oil Res. 5 (6), 639–643.
Sidibé, L., Chalchat, J.-C., Garry, R.-P., Lacombe, L., Harama, M., 2001. Aromatic
plants of Mali (IV): chemical composition of essential oils of Cymbopogon
citratus (DC) Stapf and C. giganteus (Hochst.) Chiov. J. Essent. Oil Res. 13 (2),
110–112.
Singh, A.K., Naqvi, A.A., Ram, G., Singh, K., 1994. Effect of hay storage on oil yield
and quality in three Cymbopogon Species (C. winterianus, C. martinii and C.
flexuosus) during different harvesting seasons. J. Essent. Oil Res. 6 (3), 289–294.
Stevigny, C., Block, S., Pauw-Gillet, M.C., de Hoffmann, E., Llabres, G., Adjakidje, V.,
Quetin-Leclercq, J., 2002. Cytotoxic aporphine alkaloids from Cassytha filiformis.
Planta Med. 68, 1042–1044.
Trager, W., Jensen, J.B., 1976. Human malaria parasites in continuous culture.
Science 193, 673–675.
Tyagi, B.K., Shahi, A.K., Kaul, B.L., 1998. Evaluation of repellent activities of
Cymbopogon essential oils against mosquito vectors of malaria, filariasis and
dengue fever in India. Phytomedicine 5 (4), 324–329.
VanDenDool, H., Kratz, P.D., 1963. A generalization of the retention index system
including linear temperature programmed gas–liquid partition chromatography. J. Chromatogr. A 11, 463–471.
Viana, G.S.B., Vale, T.G., Pinho, R.S.N., Matos, F.J.A., 2000. Antinociceptive effect of
the essential oil from Cymbopogon citratus in mice. J. Ethnopharmacol. 70,
323–327.
WHO/World Health Statistic, 2011. 〈www.who.int/whosis/whostat/2011/en/index.
html〉.
World Health Organisation (WHO), 2002. The WHO programme to eliminate
sleeping sickness. WHO/CDS/CSR/EPH/2002.13.